by John Conrad | May 17, 2024 | iBIO News
NewsBrief Weekly News Quiz: May 17 Life Sciences Quiz – Ready to be Tested? Think you’ve been keeping up with the whirlwind of life sciences news this week? Strap in, hotshot, because the NewsBrief Weekly Quiz is here to put your knowledge to the test!...
by John Conrad | May 17, 2024 | iBIO News
The biotech industry presents a curious picture of biotech in 2024. On one hand, there’s a funding frenzy for startups, with these young companies pulling in a whopping $3 billion in just the first quarter alone. This suggests a future brimming with excitement...
by John Conrad | May 16, 2024 | Member News
Rosalind Franklin University (RFU) recently celebrated the fifth anniversary of its Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois. The milestone coincides with the addition of four exciting new startup companies to the...
by John Conrad | May 16, 2024 | Member News
Cardio Diagnostics announced the availability of their clinical blood tests, Epi+Gen CHD and PrecisionCHD, at Family Medicine Specialists’ (FMS) newest location within the Walmart Supercenter in Round Lake Beach, Illinois. This collaboration expands access to Cardio...
by John Conrad | May 14, 2024 | iBIO News
A new study tackles a burning question: how well do drugs discovered by artificial intelligence fare in clinical trials? With AI making waves in drug discovery, this question is becoming increasingly relevant. The challenge lies in defining what constitutes an...
by John Conrad | May 14, 2024 | Member News
AbbVie has entered into a licensing deal with Gilgamesh Pharmaceuticals to develop new treatments for psychiatric disorders. AbbVie will pay Gilgamesh an upfront payment of $65 million and up to $1.95 billion in potential milestones. Gilgamesh is developing drugs...
by John Conrad | May 13, 2024 | Policy News
U.S. legislation could disrupt drug supply chain This week’s Policy Highlight looks at the BIOSECURE Act, a bill currently being debated in Congress. The Act aims to limit collaboration between U.S. companies and certain Chinese firms in the biotechnology...
by John Conrad | May 13, 2024 | Member News
In a promising development for Alzheimer’s research, Takeda Pharmaceutical Company and AC Immune SA announced a collaboration to develop and commercialize a new treatment approach. The agreement focuses on ACI-24.060, an active immunotherapy candidate designed...
by John Conrad | May 9, 2024 | iBIO News
NewsBrief Weekly News Quiz: May 10 Did you read NewsBrief this week? We’ve put together a quick quiz based on the key topics from this week’s issue. Put your life sciences knowledge to the test and see how much you remember. Power Up Your Morning with iBIO...
by John Conrad | May 9, 2024 | iBIO News
I had the exciting opportunity to present at Project Medtech’s: Midwest Showcase hosted at mHUB. It was a fantastic event, and I wanted to share some key takeaways with you all, particularly regarding iBIO’s unwavering focus on fostering the medtech...
